Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 09, 2026 08:37 ET | Source: Diversified Royalty Corp.

Diversified Royalty Corp. Announces Closing of $60 Million Bought Deal Offering of 5.75% Convertible Unsecured Subordinated Debentures

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Diversified Royalty Corp. (TSX: DIV, DIV.DB.A...
February 09, 2026 08:30 ET | Source: QuantX Biosciences, Inc.

QuantX Biosciences Closes Oversubscribed $85M Series B Financing

PRINCETON, N.J. and SHANGHAI, Feb. 09, 2026 (GLOBE NEWSWIRE) -- QuantX Biosciences, Inc., a computationally driven drug discovery and development company using advanced modeling and high-performance...
February 09, 2026 08:07 ET | Source: Bunker Hill Mining Corp.

Bunker Hill Announces C$30 Million Brokered LIFE Offering of Units & Warrant Exercise, and Reverse Stock Split

KELLOGG, Idaho and VANCOUVER, British Columbia, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX-V: BNKR | OTCQB: BHLL), is pleased to announce that...
February 09, 2026 08:07 ET | Source: Bunker Hill Mining Corp.

Bunker Hill Announces C$30 Million Brokered LIFE Offering of Units & Warrant Exercise, and Reverse Stock Split

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. KELLOGG, Idaho and VANCOUVER, British Columbia, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Bunker Hill...
February 09, 2026 08:00 ET | Source: Aerska

Aerska Raises $39M Series A Financing led by EQT Dementia Fund and age1 to Systemically Deliver RNA Medicines to the Brain

Aerska Raises $39M Series A Financing led by EQT Dementia Fund and age1 to Systemically Deliver RNA Medicines to the Brain
February 09, 2026 08:00 ET | Source: Humacyte, Inc

Humacyte Announces New U.S. Department of Defense Funding for Procurement of Bioengineered Blood Vessels

DURHAM, N.C., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at...
February 09, 2026 07:07 ET | Source: Memo Therapeutics AG

Memo Therapeutics AG Enters into a Collaboration and Option Agreement with CSL for Development of Recombinant Polyclonal IgG Technology

PRESS RELEASE Strategic research collaboration to advance MTx’s recombinant polyclonal IgG technologyAgreement includes R&D funding for exploratory work, technology access and, assuming exercise...
February 09, 2026 07:00 ET | Source: Maxim Power Corp

Maxim Power Corp. enters into a Gas Turbine and Generator Reservation Agreement and provides Prairie Lights Power Project Update

CALGARY, Alberta, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Maxim Power Corp. ("MAXIM" or the "Corporation") (TSX: MXG) announces that it has entered into a gas turbine and generator reservation agreement...
February 09, 2026 06:44 ET | Source: Microchip Technology Inc.

Microchip Technology Announces Proposed Private Offering of $600 Million of Convertible Senior Notes

CHANDLER, Ariz., Feb. 09, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: MCHP) Microchip Technology Incorporated (“Microchip”), a leading provider of smart, connected, and secure embedded control solutions,...
February 09, 2026 02:00 ET | Source: Memo Therapeutics AG

Memo Therapeutics AG Enters into a Collaboration and Option Agreement with CSL for Development of Recombinant Polyclonal IgG Technology

PRESS RELEASE Strategic research collaboration to advance MTx’s recombinant polyclonal IgG technologyAgreement includes R&D funding for exploratory work, technology access and, assuming exercise...